NASDAQ:VERV

Delisted

Verve Therapeutics Stock News

Healthcare > Biotechnology

Buy VERV

*Your capital is at risk

$11.13

+0 (+0%)

At Close: Oct 24, 2025

The Schall Law Firm Initiates Investigation Into Allegations Against Verve Therapeutics Inc And Encourages Investors With Losses To Establish Communication

05:00pm, Monday, 24'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Begins Probe Into Claims Against Verve Therapeutics Inc And Urges Investors Experiencing Losses To Initiate Contact

11:00am, Sunday, 23'rd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Starts Investigation Into Allegations Against Verve Therapeutics Inc And Encourages Investors With Losses To Establish Communication

11:00am, Saturday, 22'nd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Initiates Probe Into Claims Against Verve Therapeutics Inc And Urges Investors Suffering Losses To Initiate Contact

05:00pm, Friday, 21'st Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Begins Investigation Into Allegations Against Verve Therapeutics Inc And Encourages Investors With Losses To Reach Out

04:05pm, Thursday, 20'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

VERV Investors Have the Opportunity to Join Investigation of Verve Therapeutics, Inc. with the Schall Law Firm

12:00pm, Thursday, 20'th Jun 2024

LOS ANGELES , June 20, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics

The Schall Law Firm Has Initiated A Probe Into Claims Against Verve Therapeutics Inc And Urges Investors Who Have Suffered Losses To Make Contact

06:45pm, Wednesday, 19'th Jun 2024

The Schall Law Firm Has Begun An Investigation Into Allegations Against Verve Therapeutics Inc And Encourages Investors Who Have Incurred Losses To Reach Out

03:15pm, Tuesday, 18'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Has Initiated A Probe Into Claims Against Verve Therapeutics Inc And Urges Investors Who Have Suffered Losses To Make Contact

08:45pm, Monday, 17'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Has Begun An Investigation Into Allegations Against Verve Therapeutics, Inc. And Encourages Investors Who Have Incurred Losses To Reach Out

07:30pm, Tuesday, 11'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic

The Schall Law Firm Has Begun An Investigation Into Allegations Against Verve Therapeutics, Inc. And Encourages Investors Who Have Experienced Losses To Reach Out

11:00am, Sunday, 09'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics

The Schall Law Firm Has Initiated A Probe Into Claims Against Verve Therapeutics, Inc. And Urges Investors Who Have Suffered Losses To Get In Touch

11:00am, Saturday, 08'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics

The Schall Law Firm Announces An Investigation Into Allegations Against Verve Therapeutics, Inc. And Encourages Investors Who Have Incurred Losses To Reach Out

05:15pm, Friday, 07'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics

The Schall Law Firm Has Initiated An Examination Into Claims Against Verve Therapeutics, Inc. (NASDAQ:VERV) And Urges Investors Who Have Experienced Losses To Reach Out

12:45pm, Thursday, 06'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics

The Schall Law Firm Announces An Investigation Into Allegations Against Verve Therapeutics, Inc. (NASDAQ:VERV) And Encourages Investors With Losses To Make Contact

01:15pm, Wednesday, 05'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by